Impax Reaches $20 Million Midtrial Settlement With Retailers Over Pay-For-Delay Allegations By Sam | March 30, 2018 Impax Labs will pay $20 million to settle claims it kept its generic acne drug off the market in a “pay-for-delay” deal. Source: Drug Industry Daily Posted in Drug Industry Daily